The global animal health market size was valued at USD 39.0 Billion in 2024, and it is expected to reach USD 51.3 Billion by 2033, exhibiting a growth rate (CAGR) of 2.79% from 2025 to 2033.
To get more information on this market, Request Sample
Collaborations are centered on innovative medication delivery methods for animal health, with an emphasis on personalized solutions to increase treatment efficiency. These collaborations are propelling progress in veterinary care, with corporations employing unique technology to broaden their presence and skills in the animal health industry. For example, in December 2023, Canadian pharmaceutical manufacturing enterprise IntelGenx Corp. announced that it had entered into development and license agreements with a wholly owned subsidiary of U.S.-based Covenant Animal Health Partners, LLC. Under the terms of the agreement, the latter funded the development and manufacturing of a drug for animal health based on IntelGenx’s VetaFilm drug delivery system. This marked IntelGenx’s third collaboration in three years as it expanded its animal health business.
Moreover, partnerships in animal health are increasingly using advanced protein therapy platforms to improve treatment options. Simultaneously, corporations are reorganizing through spin-offs to focus on specific areas, such as infectious disease vaccines, assuring innovation and efficiency across several healthcare segments. For instance, in August 2023, Massachusetts-based Akston Biosciences announced that it had partnered with Delaware-based Companion Animal Health to invent, develop, and manufacture protein therapeutics. The collaboration utilized Akston's versatile Ambifect Fc-fusion platform and its cGMP biologics manufacturing facility. Additionally, it spuns off its infectious disease vaccine division into a wholly owned subsidiary, Vakston, Inc., to streamline its operations and focus on specialized segments. Furthermore, animal health solution suppliers are increasingly focused on preventative care items, such as immunizations and nutritional supplements, to decrease reliance on antibiotics, in line with worldwide health recommendations. This change addresses the rising need for sustainable livestock management techniques and increased output. Additionally, the veterinary healthcare industry has significant prospects in diagnostics and wearable technology for real-time animal health monitoring. Also, farmers and pet owners are choosing modern healthcare solutions over traditional ways on account of a need for greater efficiency and better results. For example, the rise in demand for advanced animal health solutions in North America is being driven by advancements from key businesses, such as Merck and Zoetis. These firms are developing advanced tools for diagnosis and specialized treatment choices to meet the individual requirements of livestock and companion animals while encouraging sustainable animal health practices.
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. According to the report, North America accounted for the largest animal health market share on account of a significant population of pet owners who emphasize the health and well-being of their companion animals, thereby increasing demand for veterinary products and services.
The emphasis is on precision livestock farming techniques that improve animal health and production in North America, which is fueling the regional market. Companies, such as Zoetis, are creating advanced monitoring systems that assess cattle health in real time, allowing for timely medical treatments and supporting sustainable agricultural methods.
Europe focuses on antibiotic-free animal health solutions in order to comply with severe antimicrobial legislation. For example, Denmark has widely used probiotics and vaccinations in cattle management, lowering antibiotic use while maintaining good health standards.
Due to its large rural population, Asia Pacific emphasizes on veterinary telemedicine services. Companies, such as VetOnCall, provide virtual consultations, providing access to excellent treatment for livestock and pets, particularly in countries such as India with little veterinary infrastructure.
Latin America has made major investments in immunization programs to tackle common illnesses, such as foot-and-mouth. Brazil's government-supported vaccination campaigns have substantially lowered disease outbreaks, improving animal health and increasing the region's meat export capacity.
The Middle East and Africa region focuses on disease eradication activities to alleviate cattle mortality caused by climate-related variables. For example, FAO-supported Rift Valley disease vaccine operations in Kenya have considerably increased animal survival rates and boosted the local economy.
Some of the leading animal health market companies include Bayer, Elanco, Merck, Merial, Zoetis Inc., Biogenesis Bago, Boehringer Ingelheim, Ceva Sante Animale, Heska, Neogen, Novartis, Thermo Fisher Scientific, Vetoquinol, and Virbac, among many others. For example, in February 2024, American animal health company Merck Animal Health, which focuses on developing veterinary pharmaceuticals, signed an agreement to acquire Indiana-based pharmaceutical manufacturing firm Elanco Animal Health’s aquatic-focused business for USD 1.3 Billion. The acquisition includes Elanco’s entire portfolio of medicines, vaccines, supplements, and nutrition for aquatic species, two manufacturing facilities in Vietnam and Canada, as well as a research facility in Chile.
Report Features | Details |
---|---|
Market Size in 2024 | USD 39.0 billion |
Market Forecast in 2033 | USD 51.3 billion |
Market Growth Rate 2025-2033 | 2.79% |
Units | Billion USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Animal Types Covered | Commercial, Companion |
Product Types Covered | Pharmaceuticals, Biologicals, Medicinal Feed Additives, Diagnostics |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Companies Covered | Bayer, Elanco, Merck, Merial, Zoetis Inc., Biogenesis Bago, Boehringer Ingelheim, Ceva Sante Animale, Heska, Neogen, Novartis, Thermo Fisher Scientific, Vetoquinol, Virbac. etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |